Skip to content

Study to Compare Survival for ASTRA TECH Implant System, OsseoSpeed™ Implants Following Immediate Loading in Extraction Sockets Versus Immediate Loading in Healed Ridges

An Open, Prospective, Controlled Study in the Maxilla to Evaluate Clinical Outcome of ASTRA TECH Implant System, OsseoSpeed™ Implants in Single Tooth Replacement Using an Immediate Loading Protocol in Extraction Sockets and Healed Ridges.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00710944
Enrollment
132
Registered
2008-07-08
Start date
2005-04-30
Completion date
2012-11-30
Last updated
2014-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Jaw, Edentulous, Partially

Keywords

Jaw, Edentulous, Partially (missing/extracted/avulsed teeth in the maxilla within zone 15(4)-25(13))

Brief summary

The purpose of this study is to evaluate survival for ASTRA TECH Implant System, OsseoSpeed™ implants following immediate loading in extraction sockets versus immediate loading in healed ridges. Patients in need of single standing implants replacing teeth in the maxilla within zone 15-25 will be included and followed for 5 years. Primary objective is implant survival rate at 12 months.

Interventions

ASTRA TECH Implant System, OsseoSpeed™: Ø 3.5, 4, 4.5, 5.0 mm in lengths of 8, 9, 11, 13, 15, 17 and 19 mm.

Sponsors

Dentsply Sirona Implants and Consumables
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Provision of written informed consent * 18 years of age and over * A minimum of 20 stable intra occlusal contacts after planned restoration * In need of single standing implants replacing missing / extracted / avulsed teeth in the maxilla within zone 15 to 25

Exclusion criteria

* Untreated rampant caries and uncontrolled periodontal disease * Use of smoking tobacco at time of inclusion * History of pre-surgical bone augmentation, within 4 months, in the planned implant area * History of extraction without augmentation, within 3 months in the planned implant area * Absence of opposing dentition * Absence of adjacent (mesial and/or distal) natural tooth * Uncontrolled diabetes * Known pregnancy at time of inclusion * Present alcohol or drug abuse * Any systemic or local disease or condition that would compromise post-operative healing and/or osseointegration * Need for systemic corticosteroids or any other medication that would compromise post-operative healing and/or osseointegration * Unable or unwilling to return for follow-up visits for a period of 5 years * Unrealistic esthetical demands * Unlikely to be able to comply with study procedures according to Investigators judgment * Already included in this study

Design outcomes

Primary

MeasureTime frameDescription
Implant Survival12 months after implant placementAn implant that has failed to osseointegrate, lost its osseointegration or fractured was considered a failure effective from the date of removal. The survival rate for individual implants was analyzed at each visit. Cumulative implant survival rate was calculated using Kaplan-Meier life-table estimation and reported as percentage of survived implants.

Countries

Belgium, Germany, Spain, United States

Participant flow

Participants by arm

ArmCount
Extraction Sockets
Immediate loading of implants placed in extraction sockets. ASTRA TECH Implant System, OsseoSpeed™: Ø 3.5, 4, 4.5, 5.0 mm in lengths of 8, 9, 11, 13, 15, 17 and 19 mm.
55
Healed Ridges
Immediate loading of implants placed in healed ridges. ASTRA TECH Implant System, OsseoSpeed™: Ø 3.5, 4, 4.5, 5.0 mm in lengths of 8, 9, 11, 13, 15, 17 and 19 mm.
58
Grafted Sites
Immediate loading of implants placed in grafted sites (four months healing after grafting). ASTRA TECH Implant System, OsseoSpeed™: Ø 3.5, 4, 4.5, 5.0 mm in lengths of 8, 9, 11, 13, 15, 17 and 19 mm.
19
Total132

Baseline characteristics

CharacteristicExtraction SocketsHealed RidgesGrafted SitesTotal
Age, Continuous45 years
STANDARD_DEVIATION 14
42 years
STANDARD_DEVIATION 15
40 years
STANDARD_DEVIATION 17
42 years
STANDARD_DEVIATION 17
Sex: Female, Male
Female
33 Participants33 Participants7 Participants73 Participants
Sex: Female, Male
Male
22 Participants25 Participants12 Participants59 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 550 / 580 / 19
serious
Total, serious adverse events
2 / 552 / 580 / 19

Outcome results

Primary

Implant Survival

An implant that has failed to osseointegrate, lost its osseointegration or fractured was considered a failure effective from the date of removal. The survival rate for individual implants was analyzed at each visit. Cumulative implant survival rate was calculated using Kaplan-Meier life-table estimation and reported as percentage of survived implants.

Time frame: 12 months after implant placement

Population: Per protocol analysis presented, this includes implants immediately loaded (Group A: 55 implants in 55 subjects, Group B: 58 implants in 58 subjects, Group C: 19 implants in 19 subjects), of these 5 implants in total failed within 12 months after implant placement.

ArmMeasureValue (NUMBER)
Extraction SocketsImplant Survival94.55 percentage of implants
Healed RidgesImplant Survival98.28 percentage of implants
Grafted SitesImplant Survival94.73 percentage of implants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026